Brief: Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results And Provides Business Update
11/05/2022 12:09
May 11 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS FIRST QUARTER 2022
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.26
Source text for Eikon: ID:nPnBJfJYa
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program